New Drug Applications Archive

New Drug Applications: December 2006

December 1 Merck Announces Janumet, the Trademark for its Investigational Combination Therapy of Sitagliptin Phosphate and Metformin for Type 2 Diabetes
December 8 Rimonabant Update in the United States
December 12 U.S. Food and Drug Administration Files New Drug Application for Bifeprunox, Submitted in October 2006
December 12 VIVUS Announces FDA Acceptance of EvaMist NDA Submission
December 13 Pozen Expects to Submit Revised Response to Trexima Approvable Letter by Year End
December 14 Encysive Expects to Submit Revised Response to Thelin Approvable Letter Within Several Days
December 14 Epix Pharmaceuticals to File Appeal with the Center for Drug Evaluation and Research for Vasovist
December 14 Novartis Announces Three-Month Extension of US Regulatory Review Period for Tekturna
December 15 Genta Receives Non-Approvable Notice for Application of Genasense in Patients With Chronic Lymphocytic Leukemia
December 15 Encysive Pharmaceuticals Submits Response to FDA For Thelin New Drug Application
December 15 New Drug Application Submitted for Investigational Antibiotic Doripenem
December 15 Roche Offers the FDA Additional Mircera Data
December 18 Cardiome and Astellas Pharma US, Inc. Announce Re-Submission of NDA for Vernakalant (IV)
December 18 ZymoGenetics Submits BLA to the FDA for rhThrombin as an Aid to Controlling Bleeding During Surgery
December 19 FDA Grants Torisel NDA Priority Review Status
December 19 Gilead Submits NDA To U.S. FDA for Ambrisentan for the Treatment of Pulmonary Arterial Hypertension
December 21 New River Pharmaceuticals and Shire Receive Approvable Letter for Vyvanse
December 21 Allergan Announces FDA Issues Approvable Letter for Combigan 0.2%/0.5%
December 21 Genzyme Files for Approval of Sevelamer Carbonate for Patients on Dialysis
December 22 GSK Receives Approvable Letter for Topical Antibiotic, Altabax (retapamulin ointment), 1%
December 22 Pharmacyclics Submits NDA for Xcytrin for the Treatment of Lung Cancer Brain Metastases
December 26 IDM Pharma Announces Acceptance for Review of the NDA for Junovan (Mifamurtide)
December 27 Adams Respiratory Therapeutics Seeks Approval for New Prescription Cough Suppressant
December 27 Adams Respiratory Therapeutics Seeks Approval for New Prescription Cough Suppressant
December 28 FDA Accepts Encysive’s Complete Response to Thelin New Drug Application
December 29 Nuvo Receives Approvable Letter From U.S. FDA for Pennsaid

New Drug Applications Archive

2009: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov
2008: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2007: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2006: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2005: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2004: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec

MedNotes
Advertisement

(web1)